首页 > 最新文献

BioResearch Open Access最新文献

英文 中文
Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus. 妊娠期糖尿病患者的骨循环水平和炎症标志物。
Q2 Biochemistry, Genetics and Molecular Biology Pub Date : 2018-08-01 eCollection Date: 2018-01-01 DOI: 10.1089/biores.2018.0013
Deirdre Cocks Eschler, Georgia Kulina, Adolfo Garcia-Ocana, Jiawen Li, Thomas Kraus, Carol J Levy
Abstract Gestational diabetes mellitus (GDM) can cause short- and long-term complications to the mother and fetus. While the precise mechanisms in preserving glucose balance in a healthy pregnancy are unknown, various growth factors and hormones have been implicated or associated with GDM risk in humans or rodents, including prolactin, tumor necrosis factor alpha (TNFα), osteoprotegerin (OPG), hepatocyte growth factor (HGF), and receptor activator of nuclear factor-kappa B ligand (RANKL). We aimed to evaluate the relationship of these and other protein markers in women with GDM. In this cross-sectional study, blood samples were collected from pregnant women with GDM and with normal glucose tolerance (NGT) at the 24- to 32-week obstetrical visit, during the 1-h oral glucose challenge test or 3-h oral glucose tolerance test. Blood plasma was analyzed for RANKL, OPG, prolactin, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), HGF, plasminogen activator inhibitor type 1 (PAI-1), and TNFα. Forty-six women with NGT and 47 women with GDM were included (mean ± standard deviation maternal age 31.6 ± 5.7, mean ± standard deviation gestational age 28.1 ± 2.2 weeks). Groups were similar in terms of age, body mass index, gestational age, and race/ethnicity. Serum levels of OPG, prolactin, TRAIL, HGF, PAI-1, and TNFα were similar in both groups. RANKL was lower in GDM subjects (p = 0.019). Contrary to previous reports in the literature, we found a lower serum RANKL level in women with GDM. Further investigation is needed to determine whether there are suitable serum markers for diagnosing GDM or determining prognosis or severity.
妊娠期糖尿病(GDM)可引起母亲和胎儿的短期和长期并发症。虽然在健康妊娠期间保持葡萄糖平衡的确切机制尚不清楚,但多种生长因子和激素与人类或啮齿动物的GDM风险有关,包括催乳素、肿瘤坏死因子α (TNFα)、骨保护素(OPG)、肝细胞生长因子(HGF)和核因子κ B配体受体激活剂(RANKL)。我们的目的是评估这些和其他蛋白标记物在GDM女性中的关系。在这项横断面研究中,在24- 32周的产科就诊期间,在1小时口服葡萄糖刺激试验或3小时口服葡萄糖耐量试验期间,采集GDM和正常葡萄糖耐量(NGT)孕妇的血液样本。分析血浆中RANKL、OPG、催乳素、肿瘤坏死因子相关凋亡诱导配体(TRAIL)、HGF、纤溶酶原激活物抑制剂1型(PAI-1)和TNFα的含量。纳入46例NGT妇女和47例GDM妇女(产妇平均±标准差年龄31.6±5.7,平均±标准差妊娠年龄28.1±2.2周)。各组在年龄、体重指数、胎龄和种族/民族方面相似。两组血清OPG、催乳素、TRAIL、HGF、PAI-1、TNFα水平相似。GDM组RANKL较低(p = 0.019)。与先前文献报道相反,我们发现GDM女性血清RANKL水平较低。需要进一步的研究来确定是否有合适的血清标记物来诊断GDM或确定预后或严重程度。
{"title":"Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus.","authors":"Deirdre Cocks Eschler, Georgia Kulina, Adolfo Garcia-Ocana, Jiawen Li, Thomas Kraus, Carol J Levy","doi":"10.1089/biores.2018.0013","DOIUrl":"https://doi.org/10.1089/biores.2018.0013","url":null,"abstract":"Abstract Gestational diabetes mellitus (GDM) can cause short- and long-term complications to the mother and fetus. While the precise mechanisms in preserving glucose balance in a healthy pregnancy are unknown, various growth factors and hormones have been implicated or associated with GDM risk in humans or rodents, including prolactin, tumor necrosis factor alpha (TNFα), osteoprotegerin (OPG), hepatocyte growth factor (HGF), and receptor activator of nuclear factor-kappa B ligand (RANKL). We aimed to evaluate the relationship of these and other protein markers in women with GDM. In this cross-sectional study, blood samples were collected from pregnant women with GDM and with normal glucose tolerance (NGT) at the 24- to 32-week obstetrical visit, during the 1-h oral glucose challenge test or 3-h oral glucose tolerance test. Blood plasma was analyzed for RANKL, OPG, prolactin, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), HGF, plasminogen activator inhibitor type 1 (PAI-1), and TNFα. Forty-six women with NGT and 47 women with GDM were included (mean ± standard deviation maternal age 31.6 ± 5.7, mean ± standard deviation gestational age 28.1 ± 2.2 weeks). Groups were similar in terms of age, body mass index, gestational age, and race/ethnicity. Serum levels of OPG, prolactin, TRAIL, HGF, PAI-1, and TNFα were similar in both groups. RANKL was lower in GDM subjects (p = 0.019). Contrary to previous reports in the literature, we found a lower serum RANKL level in women with GDM. Further investigation is needed to determine whether there are suitable serum markers for diagnosing GDM or determining prognosis or severity.","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/biores.2018.0013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36431963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Impact of Central Obesity on Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization. 中心性肥胖对接受体外受精的多囊卵巢综合征妇女的影响。
Q2 Biochemistry, Genetics and Molecular Biology Pub Date : 2018-08-01 eCollection Date: 2018-01-01 DOI: 10.1089/biores.2017.0040
Yu Li, Haiyan Lin, Ping Pan, Dongzi Yang, Qingxue Zhang

Central obesity (CO) is a defining characteristic of polycystic ovary syndrome (PCOS) and PCOS-induced disorders are likely to be exacerbated in the presence of CO. This study aims to evaluate the impact of CO on infertile women with PCOS undergoing in vitro fertilization (IVF).It is a retrospective and case-control study. One hundred eighty-eight infertile PCOS women undergoing IVF were divided into CO group (n = 70, waist circumference [WC] ≥80 cm) and noncentral obesity (NCO) group (n = 118, WC <80 cm). Baseline characteristics, parameters of ovarian stimulation and laboratory, and pregnancy outcomes were compared between two groups. After controlling for body mass index (BMI), WC positively correlated with fasting insulin (r = 0.210, p = 0.007), homeostatic model assessment for insulin resistance (r = 0.249, p = 0.006) and free androgen index (r = 0.249, p = 0.006). Compared with NCO group, CO group had significantly increased endocrine and metabolic disorders and needed significantly higher dose of gonadotropins, longer duration of ovarian stimulation (p < 0.05), but had significantly lower peak serum estradiol level (p < 0.01) and less oocytes retrieved (p = 0.032). CO group had significantly lower live birth and implantation rates (53.8% vs. 86.8%, p = 0.001; and 24.3% vs. 36.3%, p = 0.019, respectively) and higher early spontaneous miscarriage rate (38.5% vs. 7.5%, p = 0.002). For the multivariate analysis, by adjusting for age, BMI, insulin resistance, and hyperandrogenism (HA), CO was significantly independent risk factor for early miscarriage (adjusted relative ratio = 16.87, 95% confidence interval = 2.15-132.70, p = 0.007). CO is associated with insulin resistance, hyperinsulinemia, and HA independent of BMI and is associated with poor pregnancy outcome in infertile women with PCOS undergoing IVF.

中心性肥胖(CO)是多囊卵巢综合征(PCOS)的一个显著特征,如果存在中心性肥胖,PCOS 引起的疾病很可能会加重。本研究旨在评估 CO 对接受体外受精(IVF)的多囊卵巢综合征不孕妇女的影响。188名接受体外受精的多囊卵巢综合征不孕妇女被分为CO组(n = 70,腰围[WC]≥80厘米)和非中心性肥胖(NCO)组(n = 118,腰围r = 0.210,p = 0.007)、胰岛素抵抗稳态模型评估(r = 0.249,p = 0.006)和游离雄激素指数(r = 0.249,p = 0.006)。与 NCO 组相比,CO 组的内分泌和代谢紊乱明显增加,需要的促性腺激素剂量明显增加,卵巢刺激持续时间延长(p = 0.032)。CO 组的活产率和植入率明显较低(分别为 53.8% 对 86.8%,p = 0.001;24.3% 对 36.3%,p = 0.019),早期自然流产率较高(38.5% 对 7.5%,p = 0.002)。在多变量分析中,通过调整年龄、体重指数、胰岛素抵抗和高雄激素症(HA),CO 是早期流产的显著独立风险因素(调整相对比 = 16.87,95% 置信区间 = 2.15-132.70,p = 0.007)。CO与胰岛素抵抗、高胰岛素血症和HA有关,与体重指数无关,并且与接受体外受精的多囊卵巢综合征不孕妇女的不良妊娠结局有关。
{"title":"Impact of Central Obesity on Women with Polycystic Ovary Syndrome Undergoing <i>In Vitro</i> Fertilization.","authors":"Yu Li, Haiyan Lin, Ping Pan, Dongzi Yang, Qingxue Zhang","doi":"10.1089/biores.2017.0040","DOIUrl":"10.1089/biores.2017.0040","url":null,"abstract":"<p><p>Central obesity (CO) is a defining characteristic of polycystic ovary syndrome (PCOS) and PCOS-induced disorders are likely to be exacerbated in the presence of CO. This study aims to evaluate the impact of CO on infertile women with PCOS undergoing <i>in vitro</i> fertilization (IVF).It is a retrospective and case-control study. One hundred eighty-eight infertile PCOS women undergoing IVF were divided into CO group (<i>n</i> = 70, waist circumference [WC] ≥80 cm) and noncentral obesity (NCO) group (<i>n</i> = 118, WC <80 cm). Baseline characteristics, parameters of ovarian stimulation and laboratory, and pregnancy outcomes were compared between two groups. After controlling for body mass index (BMI), WC positively correlated with fasting insulin (<i>r</i> = 0.210, <i>p</i> = 0.007), homeostatic model assessment for insulin resistance (<i>r</i> = 0.249, <i>p</i> = 0.006) and free androgen index (<i>r</i> = 0.249, <i>p</i> = 0.006). Compared with NCO group, CO group had significantly increased endocrine and metabolic disorders and needed significantly higher dose of gonadotropins, longer duration of ovarian stimulation (<i>p</i> < 0.05), but had significantly lower peak serum estradiol level (<i>p</i> < 0.01) and less oocytes retrieved (<i>p</i> = 0.032). CO group had significantly lower live birth and implantation rates (53.8% vs. 86.8%, <i>p</i> = 0.001; and 24.3% vs. 36.3%, <i>p</i> = 0.019, respectively) and higher early spontaneous miscarriage rate (38.5% vs. 7.5%, <i>p</i> = 0.002). For the multivariate analysis, by adjusting for age, BMI, insulin resistance, and hyperandrogenism (HA), CO was significantly independent risk factor for early miscarriage (adjusted relative ratio = 16.87, 95% confidence interval = 2.15-132.70, <i>p</i> = 0.007). CO is associated with insulin resistance, hyperinsulinemia, and HA independent of BMI and is associated with poor pregnancy outcome in infertile women with PCOS undergoing IVF.</p>","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076435/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36374494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Canine Placenta Recellularized Using Yolk Sac Cells with Vascular Endothelial Growth Factor. 血管内皮生长因子诱导卵黄囊细胞再造犬胎盘。
Q2 Biochemistry, Genetics and Molecular Biology Pub Date : 2018-07-01 eCollection Date: 2018-01-01 DOI: 10.1089/biores.2018.0014
Paula Fratini, Nathia Nathaly Rigoglio, Gustavo de Sá Schiavo Matias, Ana Claudia O Carreira, Rose Eli Grassi Rici, Maria Angelica Miglino

Regenerative medicine has been growing because of the emergent need for tissues/organs for transplants and restorative surgeries. Biological scaffolds are important tools to try to solve this problem. The one used in this reserach was developed by an acellular biological scaffold from canine placenta with a rich source of cellular matrix. After decellularization, the cellular matrix demonstrated structural preservation with the presence of important functional proteins such as collagen, fibronectin, and laminin. We used cells transduced with vascular endothelial growth factor (VEGF) to recellularize this scaffold. It was succeeded by seeding the cells in nonadherent plaques in the presence of the sterelized placenta scaffold. Cells were adhered to the scaffold when analyzed by immunocytochemistry and scanning electron microscopy, both showing sprouting of yolk sac VEGF (YSVEGF) cells. This recellularized scaffold is a promissory biomaterial for repairing injured areas where neovascularization is required.

由于对用于移植和修复手术的组织/器官的迫切需求,再生医学一直在发展。生物支架是解决这一问题的重要工具。本研究中使用的支架是由犬胎盘中含有丰富细胞基质的无细胞生物支架制成的。脱细胞后,细胞基质显示出具有重要功能蛋白如胶原蛋白、纤维连接蛋白和层粘连蛋白的结构保存。我们使用血管内皮生长因子(VEGF)转导的细胞来重建这种支架。成功的方法是在固化的胎盘支架存在的情况下,将细胞植入非粘附斑块中。免疫细胞化学和扫描电镜分析细胞粘附在支架上,均显示卵黄囊VEGF (YSVEGF)细胞发芽。这种再细胞化的支架是一种有希望的生物材料,用于修复需要新生血管的损伤区域。
{"title":"Canine Placenta Recellularized Using Yolk Sac Cells with Vascular Endothelial Growth Factor.","authors":"Paula Fratini,&nbsp;Nathia Nathaly Rigoglio,&nbsp;Gustavo de Sá Schiavo Matias,&nbsp;Ana Claudia O Carreira,&nbsp;Rose Eli Grassi Rici,&nbsp;Maria Angelica Miglino","doi":"10.1089/biores.2018.0014","DOIUrl":"https://doi.org/10.1089/biores.2018.0014","url":null,"abstract":"<p><p>Regenerative medicine has been growing because of the emergent need for tissues/organs for transplants and restorative surgeries. Biological scaffolds are important tools to try to solve this problem. The one used in this reserach was developed by an acellular biological scaffold from canine placenta with a rich source of cellular matrix. After decellularization, the cellular matrix demonstrated structural preservation with the presence of important functional proteins such as collagen, fibronectin, and laminin. We used cells transduced with vascular endothelial growth factor (VEGF) to recellularize this scaffold. It was succeeded by seeding the cells in nonadherent plaques in the presence of the sterelized placenta scaffold. Cells were adhered to the scaffold when analyzed by immunocytochemistry and scanning electron microscopy, both showing sprouting of yolk sac VEGF (YSVEGF) cells. This recellularized scaffold is a promissory biomaterial for repairing injured areas where neovascularization is required.</p>","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/biores.2018.0014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36359307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
A New Approach to Treating Neurodegenerative Otologic Disorders. 一种治疗神经退行性耳科疾病的新方法。
Q2 Biochemistry, Genetics and Molecular Biology Pub Date : 2018-07-01 DOI: 10.1089/biores.2018.0017
Walter H Moos, Douglas V Faller, Ioannis P Glavas, David N Harpp, Michael H Irwin, Iphigenia Kanara, Carl A Pinkert, Whitney R Powers, Kosta Steliou, Demetrios G Vavvas, Krishna Kodukula

Hearing loss, the most common neurological disorder and the fourth leading cause of years lived with disability, can have profound effects on quality of life. The impact of this "invisible disability," with significant consequences, economic and personal, is most substantial in low- and middle-income countries, where >80% of affected people live. Given the importance of hearing for communication, enjoyment, and safety, with up to 500 million affected globally at a cost of nearly $800 billion/year, research on new approaches toward prevention and treatment is attracting increased attention. The consequences of noise pollution are largely preventable, but irreversible hearing loss can result from aging, disease, or drug side effects. Once damage occurs, treatment relies on hearing aids and cochlear implants. Preventing, delaying, or reducing some degree of hearing loss may be possible by avoiding excessive noise and addressing major contributory factors such as cardiovascular risk. However, given the magnitude of the problem, these interventions alone are unlikely to be sufficient. Recent advances in understanding principal mechanisms that govern hearing function, together with new drug discovery paradigms designed to identify efficacious therapies, bode well for pharmaceutical intervention. This review surveys various causes of loss of auditory function and discusses potential neurological underpinnings, including mitochondrial dysfunction. Mitochondria mitigate cell protection, survival, and function and may succumb to cumulative degradation of energy production and performance; the end result is cell death. Energy-demanding neurons and vestibulocochlear hair cells are vulnerable to mitochondrial dysfunction, and hearing impairment and deafness are characteristic of neurodegenerative mitochondrial disease phenotypes. Beyond acting as cellular powerhouses, mitochondria regulate immune responses to infections, and studies of this phenomenon have aided in identifying nuclear factor kappa B and nuclear factor erythroid 2-related factor 2/antioxidant response element signaling as targets for discovery of otologic drugs, respectively, suppressing or upregulating these pathways. Treatment with free radical scavenging antioxidants is one therapeutic approach, with lipoic acid and corresponding carnitine esters exhibiting improved biodistribution and other features showing promise. These compounds are also histone deacetylase (HDAC) inhibitors, adding epigenetic modulation to the mechanistic milieu through which they act. These data suggest that new drugs targeting mitochondrial dysfunction and modulating epigenetic pathways via HDAC inhibition or other mechanisms hold great promise.

听力损失是最常见的神经系统疾病,也是多年残疾的第四大原因,它会对生活质量产生深远影响。这种“看不见的残疾”在经济和个人方面产生了重大后果,其影响在中低收入国家最为严重,80%以上的受影响者生活在这些国家。鉴于听力对沟通、享受和安全的重要性,全球有多达5亿人受到影响,每年花费近8000亿美元,因此对预防和治疗新方法的研究越来越受到关注。噪音污染的后果在很大程度上是可以预防的,但不可逆转的听力损失可能是由衰老、疾病或药物副作用引起的。一旦损伤发生,治疗依赖于助听器和人工耳蜗。通过避免过度噪音和解决心血管风险等主要因素,可以预防、延迟或减少一定程度的听力损失。然而,考虑到问题的严重性,仅靠这些干预措施是不够的。在理解控制听力功能的主要机制方面的最新进展,以及旨在确定有效疗法的新药物发现范式,预示着药物干预的良好前景。这篇综述调查了听觉功能丧失的各种原因,并讨论了潜在的神经基础,包括线粒体功能障碍。线粒体减轻了细胞的保护、存活和功能,并可能屈服于能量生产和性能的累积退化;最终结果是细胞死亡。需要能量的神经元和前庭耳蜗毛细胞容易受到线粒体功能障碍的影响,听力损伤和耳聋是神经退行性线粒体疾病表型的特征。除了充当细胞动力库外,线粒体还调节对感染的免疫反应,对这一现象的研究有助于确定核因子κB和核因子红系2相关因子2/抗氧化反应元件信号分别作为发现耳科药物的靶点,抑制或上调这些途径。用清除自由基的抗氧化剂治疗是一种治疗方法,硫辛酸和相应的肉碱酯表现出改善的生物分布和其他表现出希望的特征。这些化合物也是组蛋白脱乙酰酶(HDAC)抑制剂,为其作用的机制环境添加表观遗传学调节。这些数据表明,靶向线粒体功能障碍并通过HDAC抑制或其他机制调节表观遗传途径的新药前景广阔。
{"title":"A New Approach to Treating Neurodegenerative Otologic Disorders.","authors":"Walter H Moos,&nbsp;Douglas V Faller,&nbsp;Ioannis P Glavas,&nbsp;David N Harpp,&nbsp;Michael H Irwin,&nbsp;Iphigenia Kanara,&nbsp;Carl A Pinkert,&nbsp;Whitney R Powers,&nbsp;Kosta Steliou,&nbsp;Demetrios G Vavvas,&nbsp;Krishna Kodukula","doi":"10.1089/biores.2018.0017","DOIUrl":"10.1089/biores.2018.0017","url":null,"abstract":"<p><p>Hearing loss, the most common neurological disorder and the fourth leading cause of years lived with disability, can have profound effects on quality of life. The impact of this \"invisible disability,\" with significant consequences, economic and personal, is most substantial in low- and middle-income countries, where >80% of affected people live. Given the importance of hearing for communication, enjoyment, and safety, with up to 500 million affected globally at a cost of nearly $800 billion/year, research on new approaches toward prevention and treatment is attracting increased attention. The consequences of noise pollution are largely preventable, but irreversible hearing loss can result from aging, disease, or drug side effects. Once damage occurs, treatment relies on hearing aids and cochlear implants. Preventing, delaying, or reducing some degree of hearing loss may be possible by avoiding excessive noise and addressing major contributory factors such as cardiovascular risk. However, given the magnitude of the problem, these interventions alone are unlikely to be sufficient. Recent advances in understanding principal mechanisms that govern hearing function, together with new drug discovery paradigms designed to identify efficacious therapies, bode well for pharmaceutical intervention. This review surveys various causes of loss of auditory function and discusses potential neurological underpinnings, including mitochondrial dysfunction. Mitochondria mitigate cell protection, survival, and function and may succumb to cumulative degradation of energy production and performance; the end result is cell death. Energy-demanding neurons and vestibulocochlear hair cells are vulnerable to mitochondrial dysfunction, and hearing impairment and deafness are characteristic of neurodegenerative mitochondrial disease phenotypes. Beyond acting as cellular powerhouses, mitochondria regulate immune responses to infections, and studies of this phenomenon have aided in identifying nuclear factor kappa B and nuclear factor erythroid 2-related factor 2/antioxidant response element signaling as targets for discovery of otologic drugs, respectively, suppressing or upregulating these pathways. Treatment with free radical scavenging antioxidants is one therapeutic approach, with lipoic acid and corresponding carnitine esters exhibiting improved biodistribution and other features showing promise. These compounds are also histone deacetylase (HDAC) inhibitors, adding epigenetic modulation to the mechanistic milieu through which they act. These data suggest that new drugs targeting mitochondrial dysfunction and modulating epigenetic pathways via HDAC inhibition or other mechanisms hold great promise.</p>","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/biores.2018.0017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36364505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Fatness and Fluctuating Body Weight: Effect on Central Vasculature. 肥胖和体重波动:对中枢血管的影响
Q2 Biochemistry, Genetics and Molecular Biology Pub Date : 2018-06-01 eCollection Date: 2018-01-01 DOI: 10.1089/biores.2017.0044
Zachary S Zeigler, Natasha Birchfield, Karen Moreno, Darith James, Pamela Swan

Weight Cycling (WC) is a prevalent behavior associated with adverse cardiovascular (CV) health. However, a 2010 review on the effects of WC and blood pressure (BP) determined that there was not enough evidence to draw definitive conclusions. Central BP is the principal predictor of CV risk compared to peripheral BP. The influence that WC may have specifically on central BP is unknown. Cross-sectional observation of self-reported history of WC on measures of CV health was undertaken. Seventy-five women completed a Weight and Lifestyle Inventory questionnaire, which is considered a reliable index of WC (r = 0.87, p < 0.001). Measures of visceral fat, BP, arterial stiffness, and VO2peak were taken. Regression equations were used to assess primary predictors of these outcomes. Seventy-five middle aged (39 ± 11 years), obese (32 ± 7 kg/m2), and relatively unfit (24 ± 8 ml·kg-1 min-1) women completed the study. Visceral fat was the strongest predictor of brachial systolic blood pressure (SBP; r2 = 0.283), brachial diastolic blood pressure (DBP; r2 = 0.176), central SBP (r2 = 0.375), and augmentation index (AIx; r2 = 0.535, all p < 0.001). VO2peak was the strongest predictor of central DBP (r2 = 0.062, p = 0.036) and augmentation pressure (AP; r2 = 0.491, p < 0.001). Weight cycling index was associated with visceral fat (r = 0.521, p < 0.001). Visceral fat was a mediator between WC and central SBP (confidence interval [CI] = 0.0053-0.0602), AP (CI = 0.0507-0.4915), AIx (CI = 0.0025-0.0699), and carotid-femoral pulse wave velocity (CI = 0.0115-0.1227; all p < 0.05). WC may increase visceral fat accumulation, which was associated with increased central SBP and measures of arterial stiffness.

骑自行车减肥(WC)是一种与心血管(CV)健康不利相关的普遍行为。然而,2010 年一项关于骑自行车减肥和血压(BP)影响的研究表明,没有足够的证据可以得出明确的结论。与外周血压相比,中心血压是预测心血管风险的主要指标。目前还不清楚腹围对中心血压的具体影响。我们对自我报告的 WC 史对心血管健康测量的影响进行了横断面观察。75 名女性填写了体重和生活方式调查问卷,该问卷被认为是可靠的体重指数(r = 0.87,p 2)。回归方程用于评估这些结果的主要预测因素。75 名中年(39 ± 11 岁)、肥胖(32 ± 7 kg/m2)和体能相对较差(24 ± 8 ml-kg-1 min-1)的女性完成了这项研究。内脏脂肪是肱动脉收缩压(SBP;r2 = 0.283)、肱动脉舒张压(DBP;r2 = 0.176)、中心 SBP(r2 = 0.375)和增强指数(AIx;r2 = 0.535,均为 p 2 峰值是中心 DBP(r2 = 0.062,p = 0.036)和增强压(AP;r2 = 0.491,p r = 0.521,p p
{"title":"Fatness and Fluctuating Body Weight: Effect on Central Vasculature.","authors":"Zachary S Zeigler, Natasha Birchfield, Karen Moreno, Darith James, Pamela Swan","doi":"10.1089/biores.2017.0044","DOIUrl":"10.1089/biores.2017.0044","url":null,"abstract":"<p><p>Weight Cycling (WC) is a prevalent behavior associated with adverse cardiovascular (CV) health. However, a 2010 review on the effects of WC and blood pressure (BP) determined that there was not enough evidence to draw definitive conclusions. Central BP is the principal predictor of CV risk compared to peripheral BP. The influence that WC may have specifically on central BP is unknown. Cross-sectional observation of self-reported history of WC on measures of CV health was undertaken. Seventy-five women completed a Weight and Lifestyle Inventory questionnaire, which is considered a reliable index of WC (<i>r</i> = 0.87, <i>p</i> < 0.001). Measures of visceral fat, BP, arterial stiffness, and VO<sub>2</sub>peak were taken. Regression equations were used to assess primary predictors of these outcomes. Seventy-five middle aged (39 ± 11 years), obese (32 ± 7 kg/m<sup>2</sup>), and relatively unfit (24 ± 8 ml·kg<sup>-1</sup> min<sup>-1</sup>) women completed the study. Visceral fat was the strongest predictor of brachial systolic blood pressure (SBP; <i>r</i><sup>2</sup> = 0.283), brachial diastolic blood pressure (DBP; <i>r</i><sup>2</sup> = 0.176), central SBP (<i>r</i><sup>2</sup> = 0.375), and augmentation index (AIx; <i>r</i><sup>2</sup> = 0.535, all <i>p</i> < 0.001). VO<sub>2</sub>peak was the strongest predictor of central DBP (<i>r</i><sup>2</sup> = 0.062, <i>p</i> = 0.036) and augmentation pressure (AP; <i>r</i><sup>2</sup> = 0.491, <i>p</i> < 0.001). Weight cycling index was associated with visceral fat (<i>r</i> = 0.521, <i>p</i> < 0.001). Visceral fat was a mediator between WC and central SBP (confidence interval [CI] = 0.0053-0.0602), AP (CI = 0.0507-0.4915), AIx (CI = 0.0025-0.0699), and carotid-femoral pulse wave velocity (CI = 0.0115-0.1227; all <i>p</i> < 0.05). WC may increase visceral fat accumulation, which was associated with increased central SBP and measures of arterial stiffness.</p>","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994146/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36214509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge and Acceptance of Human Papillomavirus Vaccine for Cervical Cancer Prevention Among Urban Professional Women in Bangladesh: A Mixed Method Study. 孟加拉国城市职业妇女对人乳头瘤病毒疫苗预防宫颈癌的知识和接受程度:一项混合方法研究
Q2 Biochemistry, Genetics and Molecular Biology Pub Date : 2018-05-01 eCollection Date: 2018-01-01 DOI: 10.1089/biores.2018.0007
Afsana Bhuiyan, Farhana Sultana, Jessica Yasmine Islam, Mohiuddin Ahsanul Kabir Chowdhury, Quamrun Nahar

Prophylactic human papillomavirus (HPV) vaccination is the most effective preventive method against invasive cervical cancer, the second leading cause of cancer-related deaths among women in Bangladesh. Evidence on women's knowledge and perception about cervical cancer and HPV vaccination are needed for effective implementation of national cervical cancer prevention programs. The objective of this study was to assess the knowledge, attitude, and acceptance of cervical cancer, HPV, and HPV vaccination among urban professional women in Bangladesh. We recruited 160 female professionals employed at selected private banks in Bangladesh. Participants were selected using nonprobability-based convenience sampling for interviews through a self-administered questionnaire. Later, in-depth interviews were conducted with nine of these women. Quantitative data were analyzed utilizing descriptive statistics, whereas qualitative data were analyzed using a thematic approach. Ninety-eight percent of participants reported that they had previously heard of cervical cancer, however, only half (51%) reported to have heard of HPV as a cause of the disease. Less than 1% of the 160 participants had previously undergone a pap smear, and only 2% were vaccinated with at least one dose of HPV vaccination. Although knowledge was low, intention for acceptance of vaccination was moderate for women and high for their children. Although the majority of women had heard of cervical cancer, few women had in-depth knowledge of HPV and the etiology of invasive disease. This study draws attention to the urgent need of educational interventions on cervical cancer and its prevention to improve uptake of available HPV vaccination in Bangladesh.

预防性人乳头瘤病毒(HPV)疫苗接种是预防侵袭性宫颈癌的最有效方法,而宫颈癌是孟加拉国妇女癌症相关死亡的第二大原因。为了有效实施国家宫颈癌预防规划,需要有关妇女对宫颈癌和HPV疫苗接种的知识和认知的证据。本研究的目的是评估孟加拉国城市职业妇女对宫颈癌、HPV和HPV疫苗接种的知识、态度和接受程度。我们在孟加拉国选定的私人银行招募了160名女性专业人士。参与者通过自我管理的问卷,采用基于非概率的方便抽样进行访谈。随后,我们对其中的9名女性进行了深度访谈。定量数据采用描述性统计进行分析,而定性数据采用专题方法进行分析。98%的参与者报告说他们以前听说过宫颈癌,然而,只有一半(51%)的人报告说他们听说过HPV是导致这种疾病的原因。在160名参与者中,不到1%的人以前接受过子宫颈抹片检查,只有2%的人接种了至少一剂HPV疫苗。尽管知识水平较低,但妇女接受疫苗接种的意愿中等,其子女接受疫苗接种的意愿较高。虽然大多数女性都听说过宫颈癌,但很少有女性对HPV和侵袭性疾病的病因有深入的了解。这项研究提请注意,迫切需要对宫颈癌及其预防进行教育干预,以提高孟加拉国现有HPV疫苗的吸收率。
{"title":"Knowledge and Acceptance of Human Papillomavirus Vaccine for Cervical Cancer Prevention Among Urban Professional Women in Bangladesh: A Mixed Method Study.","authors":"Afsana Bhuiyan,&nbsp;Farhana Sultana,&nbsp;Jessica Yasmine Islam,&nbsp;Mohiuddin Ahsanul Kabir Chowdhury,&nbsp;Quamrun Nahar","doi":"10.1089/biores.2018.0007","DOIUrl":"https://doi.org/10.1089/biores.2018.0007","url":null,"abstract":"<p><p>Prophylactic human papillomavirus (HPV) vaccination is the most effective preventive method against invasive cervical cancer, the second leading cause of cancer-related deaths among women in Bangladesh. Evidence on women's knowledge and perception about cervical cancer and HPV vaccination are needed for effective implementation of national cervical cancer prevention programs. The objective of this study was to assess the knowledge, attitude, and acceptance of cervical cancer, HPV, and HPV vaccination among urban professional women in Bangladesh. We recruited 160 female professionals employed at selected private banks in Bangladesh. Participants were selected using nonprobability-based convenience sampling for interviews through a self-administered questionnaire. Later, in-depth interviews were conducted with nine of these women. Quantitative data were analyzed utilizing descriptive statistics, whereas qualitative data were analyzed using a thematic approach. Ninety-eight percent of participants reported that they had previously heard of cervical cancer, however, only half (51%) reported to have heard of HPV as a cause of the disease. Less than 1% of the 160 participants had previously undergone a pap smear, and only 2% were vaccinated with at least one dose of HPV vaccination. Although knowledge was low, intention for acceptance of vaccination was moderate for women and high for their children. Although the majority of women had heard of cervical cancer, few women had in-depth knowledge of HPV and the etiology of invasive disease. This study draws attention to the urgent need of educational interventions on cervical cancer and its prevention to improve uptake of available HPV vaccination in Bangladesh.</p>","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/biores.2018.0007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36173564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Pilot Study of Dose-Response Effects of Exercise on Change in C-Reactive Protein, Cortisol, and Health-Related Quality of Life Among Cancer Survivors. 运动对癌症幸存者c -反应蛋白、皮质醇和健康相关生活质量变化的剂量反应效应的初步研究
Q2 Biochemistry, Genetics and Molecular Biology Pub Date : 2018-05-01 eCollection Date: 2018-01-01 DOI: 10.1089/biores.2018.0003
Jeanette M Ricci, Victoria Flores, Isabela Kuroyama, Arash Asher, Heather P Tarleton

Fatigue, stress, and depression contribute to poor health-related quality of life (HRQoL) among cancer survivors. This study examined the effects of combined aerobic and resistance training (CART) on HRQoL and biomarkers of stress. Cancer survivors (n = 76, 91% female, 39% breast cancer, 32% gynecologic cancer) were enrolled in CART for three 60-min sessions, weekly, for 26 weeks. Participants completed the National Institutes of Health's Patient Reported Outcomes Measurement Information System (NIH PROMIS) fatigue assessment and the SF-36. Cortisol and c-reactive protein (CRP) were assessed using volunteered blood specimens. Baseline fatigue scores were worse for participants completing treatment within the last year, compared to long-term survivors [F = (2, 59) = 3.470, p = 0.038]. After 26 weeks, fatigue scores improved by a noteworthy two points [M = 52.72, standard deviation, SD = 10.10 vs. M = 50.67, SD = 10.14; t(48) = 1.7145, p = 0.092]. Pre- to postintervention improvements in bodily pain [M = 50.54, SD = 9.51 vs. M = 48.20, SD = 10.07; t(33) = 2.913, p = 0.006] and limitations in social functioning [M = 50.60, SD = 9.17 vs. M = 47.75, SD = 11.66; t(33) = 2.206, p = 0.034], as well as a mean decrease of 1.64 ± 10.11 mg/L in CRP levels [t(107) = 1.261, p = 5.965], were observed. Participants within 1 year of treatment completion experienced greater improvements in post CRP levels compared to those who had treatment 1-4 years (p = 0.030) and 5 or more years ago (p = 0.023). Physical functioning, fatigue, fear/anxiety, social role satisfaction, and CRP levels improved following participation in this exercise intervention. Oncologists should consider recommending CART as soon as medically feasible following the cessation of cancer treatment.

疲劳、压力和抑郁导致癌症幸存者健康相关生活质量(HRQoL)较差。本研究考察了有氧和阻力联合训练(CART)对HRQoL和应激生物标志物的影响。癌症幸存者(n = 76人,91%为女性,39%为乳腺癌,32%为妇科癌症)参加CART,每周三次,每次60分钟,持续26周。参与者完成了美国国立卫生研究院的患者报告结果测量信息系统(NIH PROMIS)疲劳评估和SF-36。使用志愿者血样评估皮质醇和c反应蛋白(CRP)。与长期存活者相比,在过去一年内完成治疗的参与者的基线疲劳评分更差[F = (2,59) = 3.470, p = 0.038]。26周后,疲劳评分明显提高了2分[M = 52.72,标准差,SD = 10.10 vs. M = 50.67, SD = 10.14;T (48) = 1.7145, p = 0.092]。干预前后躯体疼痛的改善[M = 50.54, SD = 9.51 vs. M = 48.20, SD = 10.07;t(33) = 2.913, p = 0.006]和社会功能限制[M = 50.60, SD = 9.17 vs. M = 47.75, SD = 11.66;t(33) = 2.206, p = 0.034], CRP水平平均下降1.64±10.11 mg/L [t(107) = 1.261, p = 5.965]。与治疗1-4年(p = 0.030)和5年或更长时间(p = 0.023)的患者相比,治疗完成1年内的患者CRP水平有了更大的改善。参与这项运动干预后,身体功能、疲劳、恐惧/焦虑、社会角色满意度和CRP水平均有所改善。肿瘤学家应考虑在停止癌症治疗后尽快推荐CART。
{"title":"Pilot Study of Dose-Response Effects of Exercise on Change in C-Reactive Protein, Cortisol, and Health-Related Quality of Life Among Cancer Survivors.","authors":"Jeanette M Ricci,&nbsp;Victoria Flores,&nbsp;Isabela Kuroyama,&nbsp;Arash Asher,&nbsp;Heather P Tarleton","doi":"10.1089/biores.2018.0003","DOIUrl":"https://doi.org/10.1089/biores.2018.0003","url":null,"abstract":"<p><p>Fatigue, stress, and depression contribute to poor health-related quality of life (HRQoL) among cancer survivors. This study examined the effects of combined aerobic and resistance training (CART) on HRQoL and biomarkers of stress. Cancer survivors (<i>n</i> = 76, 91% female, 39% breast cancer, 32% gynecologic cancer) were enrolled in CART for three 60-min sessions, weekly, for 26 weeks. Participants completed the National Institutes of Health's Patient Reported Outcomes Measurement Information System (NIH PROMIS) fatigue assessment and the SF-36. Cortisol and c-reactive protein (CRP) were assessed using volunteered blood specimens. Baseline fatigue scores were worse for participants completing treatment within the last year, compared to long-term survivors [<i>F</i> = (2, 59) = 3.470, <i>p</i> = 0.038]. After 26 weeks, fatigue scores improved by a noteworthy two points [<i>M</i> = 52.72, standard deviation, SD = 10.10 vs. <i>M</i> = 50.67, SD = 10.14; <i>t</i>(48) = 1.7145, <i>p</i> = 0.092]. Pre- to postintervention improvements in bodily pain [<i>M</i> = 50.54, SD = 9.51 vs. <i>M</i> = 48.20, SD = 10.07; <i>t</i>(33) = 2.913, <i>p</i> = 0.006] and limitations in social functioning [<i>M</i> = 50.60, SD = 9.17 vs. <i>M</i> = 47.75, SD = 11.66; <i>t</i>(33) = 2.206, <i>p</i> = 0.034], as well as a mean decrease of 1.64 ± 10.11 mg/L in CRP levels [<i>t</i>(107) = 1.261, <i>p</i> = 5.965], were observed. Participants within 1 year of treatment completion experienced greater improvements in post CRP levels compared to those who had treatment 1-4 years (<i>p</i> = 0.030) and 5 or more years ago (<i>p</i> = 0.023). Physical functioning, fatigue, fear/anxiety, social role satisfaction, and CRP levels improved following participation in this exercise intervention. Oncologists should consider recommending CART as soon as medically feasible following the cessation of cancer treatment.</p>","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/biores.2018.0003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36121805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
The Role of Diet and Lifestyle in Women with Breast Cancer: An Update Review of Related Research in the Middle East. 饮食和生活方式在女性乳腺癌中的作用:中东相关研究的最新综述。
Q2 Biochemistry, Genetics and Molecular Biology Pub Date : 2018-05-01 eCollection Date: 2018-01-01 DOI: 10.1089/biores.2018.0004
Zainab Taha, Sakina E Eltom

Breast cancer is the most common malignancy among Arab women in Eastern Mediterranean Region (EMR). The incidence of breast cancer has substantially increased in recent years among this women population, especially those younger than 50, and the incidence is expected to double by 2030. Considerable experimental evidence supports the potential role of dietary habits and lifestyle in cancer etiology and cancer prevention. In this review we examined the literature for evidence to link dietary choices and the rise in incidence and mortality of breast cancer among women in EMR. A literature search was conducted in PubMed and Ovid MEDLINE databases up to December 2017. The search terms used are breast cancer prevalence, breast cancer incidence worldwide, breast cancer and: nutrition, protein intake, vitamin D intake, fat intake, phytoestrogens, EMR, Arab, Middle East, Gulf countries, the UAE Arab women, breast cancer risk, diet, and chemoprevention. We found evidence to suggest that there is an alarming epidemic of obesity among women in most of the EMR countries, especially Gulf Cooperation Council (GCC) countries. The rise in the new breast cancer cases among women could be attributed to excess body weight. Their dietary pattern, which correlates with obesity, can be an important factor in the etiology of cancer. Although very few studies were found to support a direct causal relationship between obesity and breast cancer in the EMR, circumstantial evidence clearly points to the possible role of the epidemic, obesity, in this population and the startling rise in cases of breast cancer. Well-designed and systematic studies are urgently needed to confirm these associations and to elucidate potential mechanisms. More urgently, calls to action are needed in many sectors and at all levels of society, to establish intensive strategies for reducing obesity and promoting an overall healthy diet. Continued and expanded research on diet, lifestyle, and breast cancer risk is urgently needed to build the foundation for future progress in evidence-based public health efforts.

乳腺癌是东地中海地区阿拉伯妇女中最常见的恶性肿瘤。近年来,乳腺癌的发病率在这些女性人群中大幅增加,尤其是50岁以下的女性,预计到2030年,发病率将翻一番。大量实验证据支持饮食习惯和生活方式在癌症病因学和癌症预防中的潜在作用。在这篇综述中,我们研究了有关饮食选择与EMR女性乳腺癌发病率和死亡率上升之间联系的文献。文献检索在PubMed和Ovid MEDLINE数据库中进行,截至2017年12月。使用的搜索词是乳腺癌患病率,全球乳腺癌发病率,乳腺癌和:营养,蛋白质摄入量,维生素D摄入量,脂肪摄入量,植物雌激素,EMR,阿拉伯,中东,海湾国家,阿联酋阿拉伯妇女,乳腺癌风险,饮食和化学预防。我们发现有证据表明,在大多数EMR国家,尤其是海湾合作委员会(GCC)国家,女性肥胖的流行程度令人担忧。女性乳腺癌新病例的增加可归因于体重过重。他们的饮食模式与肥胖有关,可能是癌症病因的一个重要因素。虽然在EMR中发现很少有研究支持肥胖和乳腺癌之间的直接因果关系,但间接证据清楚地指出,肥胖这种流行病在这一人群中的可能作用,以及乳腺癌病例的惊人增长。迫切需要精心设计和系统的研究来证实这些关联并阐明潜在的机制。更为紧迫的是,需要呼吁社会各阶层和许多部门采取行动,制定减少肥胖和促进全面健康饮食的密集战略。迫切需要继续和扩大对饮食、生活方式和乳腺癌风险的研究,为未来在以证据为基础的公共卫生工作中取得进展奠定基础。
{"title":"The Role of Diet and Lifestyle in Women with Breast Cancer: An Update Review of Related Research in the Middle East.","authors":"Zainab Taha,&nbsp;Sakina E Eltom","doi":"10.1089/biores.2018.0004","DOIUrl":"https://doi.org/10.1089/biores.2018.0004","url":null,"abstract":"<p><p>Breast cancer is the most common malignancy among Arab women in Eastern Mediterranean Region (EMR). The incidence of breast cancer has substantially increased in recent years among this women population, especially those younger than 50, and the incidence is expected to double by 2030. Considerable experimental evidence supports the potential role of dietary habits and lifestyle in cancer etiology and cancer prevention. In this review we examined the literature for evidence to link dietary choices and the rise in incidence and mortality of breast cancer among women in EMR. A literature search was conducted in PubMed and Ovid MEDLINE databases up to December 2017. The search terms used are breast cancer prevalence, breast cancer incidence worldwide, breast cancer and: nutrition, protein intake, vitamin D intake, fat intake, phytoestrogens, EMR, Arab, Middle East, Gulf countries, the UAE Arab women, breast cancer risk, diet, and chemoprevention. We found evidence to suggest that there is an alarming epidemic of obesity among women in most of the EMR countries, especially Gulf Cooperation Council (GCC) countries. The rise in the new breast cancer cases among women could be attributed to excess body weight. Their dietary pattern, which correlates with obesity, can be an important factor in the etiology of cancer. Although very few studies were found to support a direct causal relationship between obesity and breast cancer in the EMR, circumstantial evidence clearly points to the possible role of the epidemic, obesity, in this population and the startling rise in cases of breast cancer. Well-designed and systematic studies are urgently needed to confirm these associations and to elucidate potential mechanisms. More urgently, calls to action are needed in many sectors and at all levels of society, to establish intensive strategies for reducing obesity and promoting an overall healthy diet. Continued and expanded research on diet, lifestyle, and breast cancer risk is urgently needed to build the foundation for future progress in evidence-based public health efforts.</p>","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/biores.2018.0004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36189347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
LUBAC and ABIN-1 Modulate TRAIL-Based NF-κB Induction in Human Embryonic Kidney 293 Cells. LUBAC和ABIN-1调控TRAIL-Based NF-κB诱导人胚胎肾293细胞
Q2 Biochemistry, Genetics and Molecular Biology Pub Date : 2018-05-01 eCollection Date: 2018-01-01 DOI: 10.1089/biores.2018.0006
Sebastian Dorn, Christian Schoergenhofer, Michael Krainer, Markus Müller, Bernd Jilma

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is known to activate the canonical NF-κB pathway similar to TNF. The exact mechanism of the entire signaling cascade is still under investigation. The involvement of linear ubiquitylation as upregulating component has already been shown recently in some cell lines, but not in human embryonic kidney 293 (HEK293) cells. The downregulating function of the ABIN-1 (A20 binding and inhibitor of NF-κB) as linear ubiquitylation antagonist has been shown in combination with some NF-κB-inducing pathways, but not with TRAIL. We performed luciferase and western blot assays using HEK293 cells stimulated with either TRAIL (or TNF as a control) to analyze the involvement of linear ubiquitin chain assembly complex (LUBAC) components and the impact of ABIN-1 and ABIN-1-MAD (truncated form without A20 binding site) on NF-κB signaling. For overexpression experiments, we added plasmids of ABIN-1 and ABIN-1-MAD or LUBAC components HOIP, HOIL-1, or SHARPIN (single and combinations). For downregulation experiments five pairs of either SHARPIN, HOIL-1, or HOIP targeting miRNAs or one miRNA for ABIN-1 were designed and added. ABIN-1 and its truncated form ABIN-1-MAD reduced the NF-κB induction significantly indicating its involvement as antagonist (independent of deubiquitinase A20) of linear ubiquitylation in TRAIL-induced NF-κB signaling. In opposition, knockdown of ABIN-1 using a specific ABIN-1 miRNA led a clear increase of NF-κB signaling. Addition of single LUBAC components or combinations (except for SHARPIN with HOIL-1) resulted in clearly stronger NF-κB inductions. MiRNAs targeting LUBAC components significantly reduced NF-κB activation. Thus, in HEK293 cells linear ubiquitylation by LUBAC critically upregulates and ABIN-1 downregulates TRAIL-induced NF-κB signaling and may be interesting targets for future pathological therapies.

已知肿瘤坏死因子(TNF)相关凋亡诱导配体(TRAIL)可激活与TNF相似的典型NF-κB途径。整个信号级联的确切机制仍在研究中。线性泛素化作为上调成分的参与最近已经在一些细胞系中得到证实,但在人胚胎肾293 (HEK293)细胞中尚未发现。ABIN-1 (A20结合和NF-κB抑制剂)作为线性泛素化拮抗剂的下调功能已被证明与一些NF-κB诱导通路联合,但与TRAIL不一致。我们使用TRAIL(或TNF作为对照)刺激的HEK293细胞进行荧光素酶和western blot检测,以分析线性泛素链组装复合物(LUBAC)组分的参与以及ABIN-1和ABIN-1- mad(没有A20结合位点的截断形式)对NF-κB信号传导的影响。对于过表达实验,我们添加了ABIN-1和ABIN-1- mad或LUBAC成分HOIP, HOIL-1或SHARPIN(单个和组合)的质粒。设计并添加5对SHARPIN、HOIL-1或HOIP靶向miRNA或1对ABIN-1靶向miRNA进行下调实验。ABIN-1及其截断形式ABIN-1- mad显著降低NF-κB诱导,表明其作为trail诱导的线性泛素化的拮抗剂(独立于去泛素酶A20)参与NF-κB信号传导。相反,使用特定的ABIN-1 miRNA敲除ABIN-1可导致NF-κB信号的明显增加。添加单个LUBAC成分或组合(SHARPIN与HOIL-1除外)明显增强NF-κB诱导。靶向LUBAC成分的mirna显著降低NF-κB的激活。因此,在HEK293细胞中,LUBAC的线性泛素化严重上调和ABIN-1下调trail诱导的NF-κB信号,可能是未来病理治疗的有趣靶点。
{"title":"LUBAC and ABIN-1 Modulate TRAIL-Based NF-κB Induction in Human Embryonic Kidney 293 Cells.","authors":"Sebastian Dorn,&nbsp;Christian Schoergenhofer,&nbsp;Michael Krainer,&nbsp;Markus Müller,&nbsp;Bernd Jilma","doi":"10.1089/biores.2018.0006","DOIUrl":"https://doi.org/10.1089/biores.2018.0006","url":null,"abstract":"<p><p>Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is known to activate the canonical NF-κB pathway similar to TNF. The exact mechanism of the entire signaling cascade is still under investigation. The involvement of linear ubiquitylation as upregulating component has already been shown recently in some cell lines, but not in human embryonic kidney 293 (HEK293) cells. The downregulating function of the ABIN-1 (A20 binding and inhibitor of NF-κB) as linear ubiquitylation antagonist has been shown in combination with some NF-κB-inducing pathways, but not with TRAIL. We performed luciferase and western blot assays using HEK293 cells stimulated with either TRAIL (or TNF as a control) to analyze the involvement of linear ubiquitin chain assembly complex (LUBAC) components and the impact of ABIN-1 and ABIN-1-MAD (truncated form without A20 binding site) on NF-κB signaling. For overexpression experiments, we added plasmids of ABIN-1 and ABIN-1-MAD or LUBAC components HOIP, HOIL-1, or SHARPIN (single and combinations). For downregulation experiments five pairs of either SHARPIN, HOIL-1, or HOIP targeting miRNAs or one miRNA for ABIN-1 were designed and added. ABIN-1 and its truncated form ABIN-1-MAD reduced the NF-κB induction significantly indicating its involvement as antagonist (independent of deubiquitinase A20) of linear ubiquitylation in TRAIL-induced NF-κB signaling. In opposition, knockdown of ABIN-1 using a specific ABIN-1 miRNA led a clear increase of NF-κB signaling. Addition of single LUBAC components or combinations (except for SHARPIN with HOIL-1) resulted in clearly stronger NF-κB inductions. MiRNAs targeting LUBAC components significantly reduced NF-κB activation. Thus, in HEK293 cells linear ubiquitylation by LUBAC critically upregulates and ABIN-1 downregulates TRAIL-induced NF-κB signaling and may be interesting targets for future pathological therapies.</p>","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/biores.2018.0006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36189348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Novel Biomarkers of Physical Activity Maintenance in Midlife Women: Preliminary Investigation. 中年妇女维持体力活动的新生物标志物:初步调查。
Q2 Biochemistry, Genetics and Molecular Biology Pub Date : 2018-04-01 eCollection Date: 2018-01-01 DOI: 10.1089/biores.2018.0010
Kelly A Bosak, Vlad B Papa, Morgan G Brucks, Cary R Savage, Joseph E Donnelly, Laura E Martin

The precision health initiative is leading the discovery of novel biomarkers as important indicators of biological processes or responses to behavior, such as physical activity. Neural biomarkers identified by magnetic resonance imaging (MRI) hold promise to inform future research, and ultimately, for transfer to the clinical setting to optimize health outcomes. This study investigated resting-state and functional brain biomarkers between midlife women who were maintaining physical activity in accordance with the current national guidelines and previously acquired age-matched sedentary controls. Approval was obtained from the Human Subjects Committee. Participants included nondiabetic, healthy weight to overweight (body mass index 19-29.9 kg/m2) women (n = 12) aged 40-64 years. Control group data were used from participants enrolled in our previous functional MRI study and baseline resting-state MRI data from a subset of sedentary (<500 kcal of physical activity per week) midlife women who were enrolled in a 9-month exercise intervention conducted in our imaging center. Differential activation of the inferior frontal gyrus (IFG) and greater connectivity with the dorsolateral prefrontal cortex (dlPFC) was identified between physically active women and sedentary controls. After correcting for multiple comparisons, these differences in biomarkers of physical activity maintenance did not reach statistical significance. Preliminary evidence in this small sample suggests that neural biomarkers of physical activity maintenance involve activations in the brain region associated with areas involved in implementing goal-directed behavior. Specifically, activation of the IFG and connectivity with the dlPFC is identified as a neural biomarker to explain and predict long-term physical activity maintenance for healthy aging. Future studies should evaluate these biomarker links with relevant clinical correlations.

精准健康计划正在引领人们发现新的生物标志物,作为生物过程或行为反应的重要指标,比如身体活动。通过磁共振成像(MRI)识别的神经生物标志物有望为未来的研究提供信息,并最终转移到临床环境中,以优化健康结果。这项研究调查了根据现行国家指南保持身体活动的中年妇女和先前获得的年龄匹配的久坐对照组之间的静息状态和功能性脑生物标志物。已获得人类受试者委员会的批准。参与者包括40-64岁的非糖尿病、健康体重至超重(体重指数19-29.9 kg/m2)女性(n = 12)。对照组数据来自我们之前功能性MRI研究的参与者,基线静息状态MRI数据来自久坐(
{"title":"Novel Biomarkers of Physical Activity Maintenance in Midlife Women: Preliminary Investigation.","authors":"Kelly A Bosak,&nbsp;Vlad B Papa,&nbsp;Morgan G Brucks,&nbsp;Cary R Savage,&nbsp;Joseph E Donnelly,&nbsp;Laura E Martin","doi":"10.1089/biores.2018.0010","DOIUrl":"https://doi.org/10.1089/biores.2018.0010","url":null,"abstract":"<p><p>The precision health initiative is leading the discovery of novel biomarkers as important indicators of biological processes or responses to behavior, such as physical activity. Neural biomarkers identified by magnetic resonance imaging (MRI) hold promise to inform future research, and ultimately, for transfer to the clinical setting to optimize health outcomes. This study investigated resting-state and functional brain biomarkers between midlife women who were maintaining physical activity in accordance with the current national guidelines and previously acquired age-matched sedentary controls. Approval was obtained from the Human Subjects Committee. Participants included nondiabetic, healthy weight to overweight (body mass index 19-29.9 kg/m<sup>2</sup>) women (<i>n</i> = 12) aged 40-64 years. Control group data were used from participants enrolled in our previous functional MRI study and baseline resting-state MRI data from a subset of sedentary (<500 kcal of physical activity per week) midlife women who were enrolled in a 9-month exercise intervention conducted in our imaging center. Differential activation of the inferior frontal gyrus (IFG) and greater connectivity with the dorsolateral prefrontal cortex (dlPFC) was identified between physically active women and sedentary controls. After correcting for multiple comparisons, these differences in biomarkers of physical activity maintenance did not reach statistical significance. Preliminary evidence in this small sample suggests that neural biomarkers of physical activity maintenance involve activations in the brain region associated with areas involved in implementing goal-directed behavior. Specifically, activation of the IFG and connectivity with the dlPFC is identified as a neural biomarker to explain and predict long-term physical activity maintenance for healthy aging. Future studies should evaluate these biomarker links with relevant clinical correlations.</p>","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/biores.2018.0010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36032533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
BioResearch Open Access
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1